News for Aurinia Pharmaceuticals Inc. (AUP.TO)

Significant Stock Acquisition by TANG CAPITAL MANAGEMENT LLC (Trades, Portfolio) On February 28, 2025, TANG CAPITAL MANAGEMENT LLC (Trades, Portfolio) executed

On March 4, 2025, TANG KEVIN C (Trades, Portfolio), a recognized market expert, executed a significant stock transaction involving Aurinia Pharmaceuticals Inc (

On February 25, 2025, TANG CAPITAL MANAGEMENT LLC (Trades, Portfolio) executed a significant transaction by acquiring an additional 2,000,000 shares of Acelyrin

On February 13, 2025, TANG CAPITAL MANAGEMENT LLC (Trades, Portfolio) executed a significant stock transaction involving Cargo Therapeutics Inc (CRGX). The firm

On February 18, 2025, TANG CAPITAL MANAGEMENT LLC (Trades, Portfolio) executed a noteworthy transaction by acquiring 5,298,328 shares of Acelyrin Inc. This acqu

Aurinia Pharmaceuticals Inc (AUPH) has announced that it will release its financial and operational results for the fourth quarter and full year of 2024 before

Aurinia can still see growth in product revenues from Lupkynis and has a chance to show that AUR200 has some value in 2025. Learn more about AUPH stock now.

On February 7, 2025, TANG CAPITAL MANAGEMENT LLC (Trades, Portfolio) executed a significant transaction by acquiring 4,210,525 shares of Galapagos NV. This acqu

On December 31, 2024, ARMISTICE CAPITAL, LLC (Trades, Portfolio) executed a notable transaction involving Aurinia Pharmaceuticals Inc (AUPH). The firm reduced i

On December 31, 2024, TANG CAPITAL MANAGEMENT LLC (Trades, Portfolio) executed a substantial reduction in its holdings of ITeos Therapeutics Inc (ITOS). The fir

Significant Transaction in Cybin Inc On December 31, 2024, TANG CAPITAL MANAGEMENT LLC (Trades, Portfolio) executed a notable transaction involving Cybin Inc, a

On November 25, 2024, TANG CAPITAL MANAGEMENT LLC (Trades, Portfolio) made a significant move by acquiring an additional 705,433 shares of Cybin Inc (CYBN) at a

On November 21, 2024, TANG CAPITAL MANAGEMENT LLC (Trades, Portfolio) executed a notable transaction by acquiring 1,523,938 shares of Journey Medical Corp (DERM

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) commends the American College of Rheumatology (ACR) for their 2024 evidence-based guidelin

Aurinia Pharmaceuticals Inc. had a solid Q3 and announced cost cuts, sparking rumors of potential acquisition and continued profitability. Read more here.

Total Net Revenue: $67.8 million for Q3 2024, up 24% from $54.5 million in Q3 2023.Net Product Revenue: $55.5 million for Q3 2024, up 36% from $40.8 million in

Nov 07, 2024 / 01:30PM GMTOperator Greetings and welcome to Arena Pharmaceuticals third quarter, 2024 earnings call. At this time, all participants are in liste

Shares of Herbalife Ltd. (NYSE: HLF) fell sharply in today’s session following weak quarterly earnings.

Read trending news, stories and press releases from PMN Wire News about Canadian and international businesses.